Literature DB >> 29292498

Adherence to guidance on registration of randomised controlled trials published in Anaesthesia.

K El-Boghdadly1, M D Wiles2, S Atton3, C R Bailey4.   

Abstract

The International Committee of Medical Journal Editors recommends the prospective registration of interventional clinical trials. We aimed to assess the compliance with these guidelines for manuscripts submitted to and published by a single anaesthetic journal. We examined the rates of prospective trial registration, the incidence of discrepancies in primary outcome measure(s) and sample sizes, and the citation metrics of all randomised controlled trials published in Anaesthesia over a 3-year period (2014-2016). Of the 422 randomised controlled trials submitted during the study period, 115 (27.3%) were accepted for publication, of which 90 (78.3%) were patient studies, with the remaining 25 comprising manikin, simulation, volunteer, bench, cadaver and other non-patient intervention studies. Of the accepted patient studies, 64 (71.1%) were prospectively registered with a clinical trials registry, 20 (22.2%) were not registered and 6 (6.7%) were retrospectively registered after manuscript submission. There was no difference in the frequency of registration between accepted and rejected manuscripts (77.8% vs. 84.5%, respectively, p = 0.143). The median (IQR [range]) time from registration of accepted manuscripts to journal submission was 701 (331-1341 [99-2436]) days. There was no correlation between number of patients recruited to a study and time to submission. Fifty-two (81.3%) of the prospectively registered studies reported the same primary outcomes in both registration and submission, and 34 (53.1%) studies were published with the same powered sample size as that described in the registry. Eleven (12.2%) studies recruited more patients and 19 (21.1%) recruited fewer patients than described in the registration protocol. There was no difference in the median (IQR [range]) number of citations per month since publication between prospectively (0.27 (0.15-0.46 [0.00-1.59]), and retrospectively (0.39 (0.15-0.62 [0.10-0.67]); p = 0.502) or unregistered (0.33 (0.10-0.52 [0.00-0.67]); p = 0.867) studies. Our results suggest that prospective clinical trial registration has no influence on acceptance for publication by Anaesthesia or subsequent citation metrics. The international recommendation for prospective trial registration appears to have not been universally incorporated into anaesthetic-related research practice.
© 2018 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Keywords:  primary outcomes; randomised controlled trials; trial registration

Mesh:

Year:  2018        PMID: 29292498     DOI: 10.1111/anae.14103

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

Review 1.  A review identified challenges distinguishing primary reports of randomized trials for meta-research: A proposal for improved reporting.

Authors:  Stuart G Nicholls; Steve McDonald; Joanne E McKenzie; Kelly Carroll; Monica Taljaard
Journal:  J Clin Epidemiol       Date:  2022-01-23       Impact factor: 7.407

2.  Trial registration and selective outcome reporting in 585 clinical trials investigating drugs for prevention of postoperative nausea and vomiting.

Authors:  Manuel Riemer; Peter Kranke; Antonia Helf; Debora Mayer; Maria Popp; Tobias Schlesinger; Patrick Meybohm; Stephanie Weibel
Journal:  BMC Anesthesiol       Date:  2021-10-19       Impact factor: 2.217

3.  Analysis of the distribution and scholarly output from National Institute of Academic Anaesthesia (NIAA) research grants.

Authors:  K El-Boghdadly; A B Docherty; A A Klein
Journal:  Anaesthesia       Date:  2018-03-30       Impact factor: 6.955

4.  Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations.

Authors:  Mustafa Al-Durra; Robert P Nolan; Emily Seto; Joseph A Cafazzo
Journal:  BMJ       Date:  2020-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.